Coherus Oncology, Inc.CHRSNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank46
3Y CAGR+11.6%
5Y CAGR+9.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+11.6%/yr
vs -70.4%/yr prior
5Y CAGR
+9.2%/yr
Consistent
Acceleration
+82.0pp
Accelerating
Percentile
P46
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.05 | +584.4% |
| 2024 | 0.59 | -51.4% |
| 2023 | 1.22 | -58.2% |
| 2022 | 2.91 | -21.0% |
| 2021 | 3.69 | +41.4% |
| 2020 | 2.61 | -26.0% |
| 2019 | 3.52 | -99.1% |
| 2018 | 378.12 | +25.8% |
| 2017 | 300.50 | +4741.9% |
| 2016 | 6.21 | - |